ISTANBUL JOURNAL OF PHARMACY, vol.50, no.2, pp.125-130, 2020 (ESCI)
Background and Aims: Myeloperoxidase (MPO, EC 1.11.2.2) is a vital antimicrobial enzyme, having a crucial role in host defense. Obstructing the activity of MPO is a possible pharmacological approach for the hindrance and management of a wide array of inflammatory illnesses. Consequently, blocking the activity of MPO is a potential pharmacological strategy for prevention and treatment of a broad range of inflammatory diseases.